Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lock

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Molecular Cancer Therapeutics|November 16, 2011
Induction of vascular endothelial growth factor secretion by childhood acute lymphoblastic leukemia cells via the FLT-3 signaling pathwayAna Markovic, Karen L MacKenzie, Richard B Lock
The International Journal of Biochemistry & Cell Biology|March 22, 2005
FLT-3: a new focus in the understanding of acute leukemiaAna Markovic, Karen L MacKenzie, Richard B Lock
Cancer Chemotherapy and Pharmacology|April 29, 1998
Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2'-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicinM J Elliott, L Stribinskiene, R B Lock
Methods in Molecular Medicine|May 25, 2005
Preclinical testing of antileukemic drugs using an in vivo model of systemic diseaseRichard B Lock, Natalia L Liem, Rachael A Papa
Oncogene|November 11, 1999
Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2K M Murphy, U N Streips, R B Lock
The Journal of Biological Chemistry|April 7, 2000
Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocationK M Murphy, U N Streips, R B Lock
Journal of Paediatrics and Child Health|November 5, 2011
Glucocorticoid resistance in paediatric acute lymphoblastic leukaemiaVivek A Bhadri, Toby N Trahair, Richard B Lock
Leukemia & Lymphoma|April 25, 2007
Xenograft models for the preclinical evaluation of new therapies in acute leukemiaErwin M Lee, Petra S Bachmann, Richard B Lock
Frontiers in Oncology|April 9, 2020
Long Non-coding RNAs: Major Regulators of Cell Stress in CancerPatrick Connerty, Richard B Lock, Charles E de Bock
Immunological Reviews|December 1, 1990
Antigen recognition and peptide-mediated immunotherapy in autoimmune diseaseD E Smilek, C B Lock, H O McDevitt
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Molecular Cancer Therapeutics|November 16, 2011
Induction of vascular endothelial growth factor secretion by childhood acute lymphoblastic leukemia cells via the FLT-3 signaling pathwayAna Markovic, Karen L MacKenzie, Richard B Lock
The International Journal of Biochemistry & Cell Biology|March 22, 2005
FLT-3: a new focus in the understanding of acute leukemiaAna Markovic, Karen L MacKenzie, Richard B Lock
Cancer Chemotherapy and Pharmacology|April 29, 1998
Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2'-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicinM J Elliott, L Stribinskiene, R B Lock
Methods in Molecular Medicine|May 25, 2005
Preclinical testing of antileukemic drugs using an in vivo model of systemic diseaseRichard B Lock, Natalia L Liem, Rachael A Papa
Oncogene|November 11, 1999
Bax membrane insertion during Fas(CD95)-induced apoptosis precedes cytochrome c release and is inhibited by Bcl-2K M Murphy, U N Streips, R B Lock
The Journal of Biological Chemistry|April 7, 2000
Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocationK M Murphy, U N Streips, R B Lock
Journal of Paediatrics and Child Health|November 5, 2011
Glucocorticoid resistance in paediatric acute lymphoblastic leukaemiaVivek A Bhadri, Toby N Trahair, Richard B Lock
Leukemia & Lymphoma|April 25, 2007
Xenograft models for the preclinical evaluation of new therapies in acute leukemiaErwin M Lee, Petra S Bachmann, Richard B Lock
Frontiers in Oncology|April 9, 2020
Long Non-coding RNAs: Major Regulators of Cell Stress in CancerPatrick Connerty, Richard B Lock, Charles E de Bock
Immunological Reviews|December 1, 1990
Antigen recognition and peptide-mediated immunotherapy in autoimmune diseaseD E Smilek, C B Lock, H O McDevitt
Pageof 22